{"slideshow_credits": null, "snippet": "Identifying which patients are likely to benefit from expensive treatments such as Opdivo, Yervoy and Keytruda could save money and prevent side effects.", "abstract": "Doctors are underscoring need for test that can determine whether expensive immune-boosting drugs like Opdivo and Yervoy will work on cancer patients in advance, as drugs help only minority of patients, but work exceedingly well; challenges of creating test are both ethical and scientific; importance of test has been laid out in study published in New England Journal of Medicine.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/06/01/business/doctors-seek-test-for-deploying-new-life-extending-cancer-drugs.html", "lead_paragraph": "Identifying which patients are likely to benefit from expensive treatments such as Opdivo, Yervoy and Keytruda could save money and prevent side effects.", "headline": {"main": "Doctors Seek Test for Deploying New Life-Extending Cancer Drugs", "print_headline": "Specialists Seeking Tests for Deploying New Life-Extending Cancer Drugs"}, "_id": "556af0d238f0d87ed70a5338", "word_count": "1097", "multimedia": [{"height": 126, "url": "images/2015/05/31/business/01SKIN-web/01SKIN-web-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/05/31/business/01SKIN-web/01SKIN-web-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 401, "url": "images/2015/05/31/business/01SKIN-web/01SKIN-web-articleLarge.jpg", "legacy": {"xlarge": "images/2015/05/31/business/01SKIN-web/01SKIN-web-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "401"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/05/31/business/01SKIN-web/01SKIN-web-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/05/31/business/01SKIN-web/01SKIN-web-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-06-01T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Cancer", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Tests (Medical)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "New England Journal of Medicine", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Lung Cancer", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Immune System", "is_major": "N", "rank": "6"}, {"name": "organizations", "value": "Memorial Sloan-Kettering Cancer Center", "is_major": "N", "rank": "7"}, {"name": "subject", "value": "Tumors", "is_major": "N", "rank": "8"}, {"name": "subject", "value": "Melanomas", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": null, "type_of_material": "News"}